SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Barry Myers is a featured speaker at CED's MedTech 2008 Conference in Durham, NC
News | 03. 08. 2008
